Astria Therapeutics to Present at Upcoming European Academy of Allergy and Clinical Immunology Congress
23 Maggio 2024 - 2:00PM
Business Wire
Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical
company focused on developing life-changing therapies for allergic
and immunological diseases, today announced that it will present
two posters at the upcoming European Academy of Allergy and
Clinical Immunology (EAACI) Congress in Valencia, Spain on June 1,
2024.
- Dr. Marcus Maurer, M.D., Professor of Dermatology and Allergy
at Charité Universitätsmedizin in Berlin, will present information
on ALPHA-SOLAR, a long-term open-label trial of STAR-0215 in people
living with HAE, in a poster titled “Rationale and Design of the
ALPHA-SOLAR Clinical Trial of STAR-0215 for the Treatment of
Hereditary Angioedema (HAE).” The poster session will take place on
Saturday, June 1 at 12:00pm CEST.
- Nikos Biris, Ph.D., Senior Director of Assay Development at
Astria Therapeutics, will present information on the
characterization of STAR-0310 in a poster titled “Development and
Characterization of STAR-0310: a Novel OX40 Antagonistic Monoclonal
Antibody.” The poster session will take place on Saturday, June 1
at 12:00pm CEST.
About Astria Therapeutics:
Astria Therapeutics is a biopharmaceutical company, and our
mission is to bring life-changing therapies to patients and
families affected by allergic and immunological diseases. Our lead
program, STAR-0215, is a monoclonal antibody inhibitor of plasma
kallikrein in clinical development for the treatment of hereditary
angioedema. Our second program, STAR-0310, is a monoclonal antibody
OX40 antagonist in preclinical development for the treatment of
atopic dermatitis. Learn more about our company on our website,
www.astriatx.com, or follow us on X and Instagram @AstriaTx and on
Facebook and LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240523463861/en/
Astria Contact: Investor
Relations and Media: Elizabeth Higgins
investors@astriatx.com
Grafico Azioni Astria Therapeutics (NASDAQ:ATXS)
Storico
Da Dic 2024 a Gen 2025
Grafico Azioni Astria Therapeutics (NASDAQ:ATXS)
Storico
Da Gen 2024 a Gen 2025
